Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
PharmaFlair - B2B Pharma Marketplace
pharmaflair.in
Deepak Bhardwaj
7087772935

Bookmark and Share
B2B Pharma Marketplace - PharmaFlair launched Antimalarial Medicine for PCD Pharma Franchise
To Deal with chronic & Pandemic Diseases like Coronavirus, Dengue, Maleriya we need Anti Vaccene, Medication to meet the Continuously increasing demand for such products. PharmaFlair launched Antimalarial Medication for PCD Pharma Franchise

BriefingWire.com, 4/06/2020 - Antimalarial medicine are used to treat malaria caused by the bite of an infected anopheles mosquito, then the infection of a certain protozoan is transmitted to the person. This condition is known as malaria. A malarial patient experiences anemia, chills, and fever. Malaria can be prevented by the use of antimalarial medicines as a prophylactic measure before entering an endemic area.

The global anti-malarial market is anticipated to record a significant CAGR over a forecast period. The Malarial Market was accounted for $711,360 thousand in 2018 and is expected to reach $1,019,396 thousand by 2026, registering a CAGR of 4.6% from 2019 to 2026. The increasing R&D activities for new combinations of formulations, due to resistance by the parasites to the currently available molecules, are also expected to drive the global anti-malarial market.

The global antimalarial market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Alvizia Healthcare Pvt. Ltd., Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Merck & Co., Inc, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), and Zydus Cadila.

To Deal with chronic & Pandemic Diseases like Coronavirus, Dengue, Maleriya we need Anti Vaccene, Drugs to meet the Continuously increasing demand for such products. PharmaFlair launched Antimalarial medicines business category for PCD Pharma Franchise to maintain the supply of these medicine into Domestic market.

PharmaFlair- Online B2B Pharma Marketplace incepted in 2017 heading towards it’s goal to bring Pharma Manufacturer, Traders offers franchise Opportunities of the best quality GMP Pharma products. PharmaFlair has 500 Business listed and received 7000 Business queries in 2019–20. PharmaFlair has 3500+ GMP-WHO products listed in its platform offered by Best Pharma, Healthcare & Medical Product manufacturers & traders in India.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2024 Proserve Technology, Inc.